Earnings · US stocks
Unicycive Therapeutics, Inc. (UNCY) earnings
Unicycive Therapeutics, Inc. published its quarterly report on 2026-11-16. The stock moved +0.56% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-16
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +4.23% | — |
| 3 days | +0.56% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 6 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +3.63%).
| Published | EPS YoY | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|
| 2026-11-16 | — | -0.25 | +28.80% | +0.56% | — | — |
| 2026-08-12 | — | -0.06 | +81.74% | +10.20% | -3.80% | -3.44% |
| 2026-03-30 | — | -0.82 | -80.00% | +11.42% | +24.41% | +7.82% |
| 2025-11-12 | — | -0.33 | +38.12% | +18.37% | +22.34% | +21.26% |
| 2025-08-14 | -134.70% | -0.52 | +25.56% | -7.48% | -15.19% | -17.23% |
| 2025-05-14 | — | -0.50 | +19.35% | -1.65% | -90.20% | -94.46% |
| 2025-03-31 | — | -2.60 | -271.43% | +2.61% | +5.39% | +0.48% |
| 2024-11-13 | — | -0.50 | +67.03% | -4.96% | +63.22% | +62.48% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.